Establishing plausibility of cardiovascular adverse effects of immunotherapies using Mendelian randomisation
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2023.1116799
Abstract: Immune checkpoint inhibitors (ICIs) and Janus kinase inhibitors (JAKis) have raised concerns over serious unexpected cardiovascular adverse events. The widespread pleiotropy in genome-wide association studies offers an opportunity to identify cardiovascular risks from in-development drugs… read more here.
Keywords: stroke risk; cardiovascular adverse; risk; ischemic stroke ... See more keywords